PHARMASSET INC Research and Development Expense
PHARMASSET INC reported Research and Development Expense of $75.85 million for the 12-month period ending 2011-09-30, per its 10-K filed 2011-11-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2011-11-14
- PHARMASSET INC research and development expense for the quarter ending 2011-09-30 was $21.17M, a 36.32% increase year-over-year.
- PHARMASSET INC research and development expense for the quarter ending 2011-06-30 was $18.92M, a 64.42% increase year-over-year.
- PHARMASSET INC research and development expense for the quarter ending 2010-09-30 was $15.53M.
- PHARMASSET INC research and development expense for the quarter ending 2010-06-30 was $11.51M.
- PHARMASSET INC research and development expense for fiscal 2011 was $75.85M, a 57.17% increase from fiscal 2010.
- PHARMASSET INC research and development expense for fiscal 2010 was $48.26M, a 8.17% decline from fiscal 2009.
- PHARMASSET INC research and development expense for fiscal 2009 was $52.55M.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|
| 2011-09-30 | $21.17M derived: 10-K 12 month − 10-Q 9 month · filed 2011-11-14 | $40.09M derived: sum of 2 quarters · filed 2011-11-14 | $75.85M 10-K · filed 2011-11-14 | |
| 2011-06-30 | $18.92M 10-Q · filed 2011-08-09 | $54.68M 10-Q · filed 2011-08-09 | ||
| 2010-09-30 | $15.53M derived: 10-K 12 month − 10-Q 9 month · filed 2011-11-14 | $27.04M derived: sum of 2 quarters · filed 2011-11-14 | $48.26M 10-K · filed 2011-11-14 | |
| 2010-06-30 | $11.51M 10-Q · filed 2011-08-09 | $32.73M 10-Q · filed 2011-08-09 | ||
| 2009-09-30 | $52.55M 10-K · filed 2011-11-14 |